Brian Kobilka
Corporate Officer/Principal at Stanford University
Profile
Brian Kobilka is the founder of Epiodyne, Inc. which was founded in 2016.
He is currently a Professor at Stanford University.
Previously, he worked as the Director at Keystone Symposia and as a Scientific Advisor at Inverseon, Inc.
Brian Kobilka active positions
Companies | Position | Start |
---|---|---|
Stanford University | Corporate Officer/Principal | 14/04/2010 |
Former positions of Brian Kobilka
Companies | Position | End |
---|---|---|
Inverseon, Inc.
Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Inverseon, Inc. is a private company developing a re-profiled beta blocker for the treatment of asthma and COPD. Inverseon’s scientific approach, “Paradoxical Pharmacology”, is based on observations that chronic effects of inverse agonist drugs are completely opposite to their acute effects. A similar paradigm shift occurred in the late 1990’s with the approval of the first beta blocker for congestive heart failure, a disease state where the drug was also originally contraindicated. Inverseon’s scientific founder, Professor Richard Bond, identified the mechanism of action as inverse agonism at the beta adrenergic receptor and hypothesized that this observation represented a general pharmacological phenomenon and identified asthma as another disease to target. To date, the company has achieved a number of important milestones: completing two open-label Phase 2a studies demonstrating a dose-response, a comment in The Lancet in 2009 highlighting the published human clinical trial, and 2009 issuance of their first U.S. patent. | Director/Board Member | 31/08/2012 |
Keystone Symposia
Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO. | Director/Board Member | - |
Epiodyne, Inc.
Epiodyne, Inc. Pharmaceuticals: MajorHealth Technology Epiodyne, Inc. engages in biotechnology services. The company was founded by Brian Shoichet, Brian Kobilka, Peter Gmeiner, Bryan L. Roth, Gregory Scherrer, and Aashish Manglik in 2016 and is headquartered in San Francisco, CA. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Inverseon, Inc.
Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Inverseon, Inc. is a private company developing a re-profiled beta blocker for the treatment of asthma and COPD. Inverseon’s scientific approach, “Paradoxical Pharmacology”, is based on observations that chronic effects of inverse agonist drugs are completely opposite to their acute effects. A similar paradigm shift occurred in the late 1990’s with the approval of the first beta blocker for congestive heart failure, a disease state where the drug was also originally contraindicated. Inverseon’s scientific founder, Professor Richard Bond, identified the mechanism of action as inverse agonism at the beta adrenergic receptor and hypothesized that this observation represented a general pharmacological phenomenon and identified asthma as another disease to target. To date, the company has achieved a number of important milestones: completing two open-label Phase 2a studies demonstrating a dose-response, a comment in The Lancet in 2009 highlighting the published human clinical trial, and 2009 issuance of their first U.S. patent. | Health Technology |
Epiodyne, Inc.
Epiodyne, Inc. Pharmaceuticals: MajorHealth Technology Epiodyne, Inc. engages in biotechnology services. The company was founded by Brian Shoichet, Brian Kobilka, Peter Gmeiner, Bryan L. Roth, Gregory Scherrer, and Aashish Manglik in 2016 and is headquartered in San Francisco, CA. | Health Technology |
Keystone Symposia
Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO. | Commercial Services |
- Stock Market
- Insiders
- Brian Kobilka